Insider · CIK 0001865699

Farquharson Andrew

Reports to the SEC for 1 company · SAN JOSE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001865699

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-28	RANIRani Therapeutics Holdings, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2024-05-29	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2023-05-25	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2022-08-23	RANIRani Therapeutics Holdings, Inc.C Conversion	Director	CConversion	−7,694 sh	—	—	248,929
2022-08-23	RANIRani Therapeutics Holdings, Inc.C Conversion	Director	CConversion	+7,694 sh	—	—	72,818
2022-08-23	RANIRani Therapeutics Holdings, Inc. · Class A Common LLC UnitsC Conversion	Director	CConversion	−7,694 sh	—	—	248,929
2022-08-17	RANIRani Therapeutics Holdings, Inc.S Sale	Director	SSale	−71K sh	$10.51	−$747K	74,334
2022-08-17	RANIRani Therapeutics Holdings, Inc.S Sale	Director	SSale	−9,210 sh	$11.62	−$107K	65,124
2022-05-25	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.4K sh	—	—	41,416
2022-03-07	RANIRani Therapeutics Holdings, Inc.C Conversion	Director	CConversion	−2.31M sh	—	—	256,623
2022-03-07	RANIRani Therapeutics Holdings, Inc.C Conversion	Director	CConversion	+2.31M sh	—	—	2,375,617
2022-03-07	RANIRani Therapeutics Holdings, Inc.J Other	Director	JOther	−2.23M sh	—	—	146,379
2022-03-07	RANIRani Therapeutics Holdings, Inc. · Class A Common LLC UnitsC Conversion	Director	CConversion	−2.31M sh	—	—	256,623
2022-02-03	RANIRani Therapeutics Holdings, Inc.J Other	Director	JOther	−827K sh	—	—	0
2022-02-03	RANIRani Therapeutics Holdings, Inc.J Other	Director	JOther	+66.1K sh	—	—	66,127

Recent filings

Accepted (ET)
May 304
Farquharson Andrew0001415889-25-015032
SEC(opens sec.gov)
Dec 174
Farquharson Andrew0000950170-24-137315
SEC(opens sec.gov)
May 304
Farquharson Andrew0000950170-24-066582
SEC(opens sec.gov)
Dec 194
Farquharson Andrew0000950170-23-071467
SEC(opens sec.gov)
May 304
Farquharson Andrew0001209191-23-033042
SEC(opens sec.gov)
Aug 254
Farquharson Andrew0001209191-22-047662
SEC(opens sec.gov)
Aug 194
Farquharson Andrew0001209191-22-046957
SEC(opens sec.gov)
May 274
Farquharson Andrew0000899243-22-019859
SEC(opens sec.gov)
Mar 104
Farquharson Andrew0001179110-22-002127
SEC(opens sec.gov)
Feb 74
Farquharson Andrew0001209191-22-007637
SEC(opens sec.gov)

Companies

Rani Therapeutics Holdings, Inc.DirectorRANI

Address

C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE.

SAN JOSE, CA, 95131